Streamlining Patient Recruitment with AI–driven Site Identification
Access Your Copy of the White Paper
Finding high-volume sites is key to successful patient recruitment in clinical trials. This white paper describes how Verana Health leveraged its exclusive data partnership with the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) coupled with its expertise in healthcare data and analytics—including AI techniques to extract key criteria from unstructured notes—to facilitate site identification and patient recruitment for a phase 2 clinical trial.
%20(1).png?width=308&height=400&name=Verana_Health_-_Patient_Recruitment_Whitepaper_Cover%20(1)%20(1).png "Verana_Health_-_Patient_Recruitment_Whitepaper_Cover (1) (1)")
This white paper includes:
-
The challenges of patient recruitment for challenging indications, particularly those without ICD codes
-
How real-world data (RWD) and artificial intelligence (AI) can be leveraged to identify high-volume study sites to support recruitment
-
A Verana Health case study highlighting the use of their exclusive access to RWD facilitate patient recruitment and support site selection for a unique indication
Complete the form to access your copy.
Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.
